Zinger Key Points
- Sen. Agard said she will "thoroughly" review the medical marijuana bill the Republicans introduced on Monday.
- Assembly Speaker Robin Vos said the bill represents the maximum extent that Republicans are willing to go.
A long-time cannabis advocate and lawmaker, State Senator Melissa Agard (D-Madison) is determined to carefully assess a medical marijuana bill that Wisconsin's Republican legislators introduced on Monday.
"I am thoroughly reviewing every provision of this bill because the devil truly is in the details," Agard said in a statement reported by WisPolitics. "This is a serious matter the legislature will be taking up in the coming weeks."
Agard, who has been tireless in her efforts to enact cannabis policy reform said the GOP-backed legislation is "overly restrictive,” which “does not move our state in the right direction."
Assembly Speaker Robin Vos seems to not only be of the opposite opinion, but he says the bill represents the maximum extent that Republicans are willing to go.
The legislation stipulates stringent eligibility criteria, limiting marijuana access to patients diagnosed with specific conditions, including cancer, glaucoma, multiple sclerosis, severe muscle spasms, and terminal illnesses, among others.
Agard begs to differ. "It is disappointing to see that yet again, Wisconsin's Republican Legislators are acting as health professionals when they are not," she said. "I firmly believe we must trust doctors, patients, and caretakers to make these personal, medical decisions."
Some Are Cautions, Some Applaud
Democratic Senate Minority Leader Dianne Hesselbein shared Agard's concerns regarding the bill’s restrictions though she called it a "small step in the right direction," writes the Associated Press.
Governor Tony Evers (D) and the Democrats have long advocated full marijuana legalization for years.
Even though the new measure falls short of their goals, Evers expressed openness to a Republican-backed proposal for limited medical marijuana legalization recently.
On Monday, he showed no indication of whether he supported or opposed the proposal.
Britt Cudaback, the governor's spokesperson said Evers will evaluate the concept and provide his feedback while looking forward to “hearing from Wisconsinites and other stakeholders as the bill moves through" the state Assembly and Senate.
Republican Senate Majority Leader Devin LeMahieu, who acknowledged last year the potential passage of a medical marijuana bill within this legislative session, was also cautious about sharing his stance. He said the bill should be "thoroughly vetted before the Senate decides how to proceed."
LeMahieu's political ally Rep. Angie Sapik seems to fully support the bill.
"The new legislation aims to provide a common-sense and clear solution for many elderly and chronic condition sufferers, offering safeguards and clear medical prescription and benefits to everyday Wisconsinites," she said.
Missed the first wave of cannabis investments? Don't make that mistake again.
Experts believe cannabis stocks have found their floor and are now poised for unprecedented growth.
Join Benzinga PotProfits. Our in-house canna stock expert, Michael Berger, is on a mission to uncover the most promising cannabis stocks poised for growth, even in a dull market. He leaves no bud unturned to bring you the juiciest potential double-digit opportunities!
Just this year, the PotProfits portfolio has seen smoking-hot gains like:
- 47.10% with $GTBIF
- 40.23% with $TCNNF
- 21.50% with $VFF
But here's the kicker: Michael is about to release his next potential winners, and he's chomping at the bit to share these ticker symbols with you ASAP.
Don't miss out on the green rush!
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.